{"id":"systane-ultra","safety":{"commonSideEffects":[{"rate":null,"effect":"Blurred vision"},{"rate":null,"effect":"Eye irritation"},{"rate":null,"effect":"Ocular discomfort"}]},"_chembl":null,"_dailymed":{"setId":"0537c23a-15f7-be64-1231-a6c93468e9a8","title":"SYSTANE ULTRA (POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL) SOLUTION/ DROPS [ALCON LABORATORIES, INC.]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The formulation combines polyethylene glycol 400 and propylene glycol as active lubricating agents with a gelling system to create a protective film over the cornea and conjunctiva. This extended-release formulation is designed to provide longer-lasting relief from dry eye symptoms by maintaining moisture on the ocular surface and reducing tear evaporation.","oneSentence":"Systane Ultra is an artificial tear lubricant that provides sustained ocular surface hydration and protection.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:10:40.866Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Dry eye syndrome / Keratoconjunctivitis sicca"}]},"trialDetails":[{"nctId":"NCT05902364","phase":"NA","title":"Systane® Ultra Preservative Free Lubricant Eye Drops","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2023-10-28","conditions":"Dry Eye","enrollment":69},{"nctId":"NCT06379685","phase":"PHASE1","title":"Study to Evaluate the Safety and Tolerability of PRO-190 Ophthalmic Solution Compared to Systane Ultra® on the Ocular Surface.","status":"NOT_YET_RECRUITING","sponsor":"Laboratorios Sophia S.A de C.V.","startDate":"2025-12-30","conditions":"Dry Eye, Dry Eyes Chronic, Dry Eye Syndromes","enrollment":32},{"nctId":"NCT04393441","phase":"PHASE3","title":"Efficacy and Safety of a New Artificial Tear Formulation Compared With Systane Ultra Multidose in Participants With Dry Eye Disease","status":"COMPLETED","sponsor":"Allergan","startDate":"2020-06-29","conditions":"Dry Eye Disease (DED)","enrollment":400},{"nctId":"NCT02985827","phase":"PHASE4","title":"Symptom Response in Normal and Dry Eye Patients Secondary to Application of a Menthol-Containing Eyedrop (Rohto® Hydra)","status":"COMPLETED","sponsor":"ORA, Inc.","startDate":"2015-12","conditions":"Dry Eye","enrollment":48},{"nctId":"NCT03223909","phase":"PHASE4","title":"Efficacy and Safety of the Ophthalmic Solution PRO-087 Versus Systane ® Ultra and Ultra Preservative Free (087LATAMFIV)","status":"COMPLETED","sponsor":"Laboratorios Sophia S.A de C.V.","startDate":"2016-10-13","conditions":"Dry Eye Syndrome","enrollment":326},{"nctId":"NCT03524157","phase":"PHASE1","title":"Safety and Tolerability of PRO-087 Versus Xyel Ofteno® and Systane Ultra®, on the Ocular Surface of Healthy Subjects","status":"COMPLETED","sponsor":"Laboratorios Sophia S.A de C.V.","startDate":"2017-07-17","conditions":"Dry Eye Syndromes, Lubricant Allergy, Tear Disorder","enrollment":30},{"nctId":"NCT03706443","phase":"NA","title":"Tear Lipid Layer Thickness Changes With Use of Emollient and Non-Emollient Eye Drops","status":"COMPLETED","sponsor":"Ohio State University","startDate":"2018-12-05","conditions":"Dry Eye Syndromes, Keratoconjunctivitis Sicca, Lacrimal Apparatus Diseases","enrollment":24},{"nctId":"NCT02446015","phase":"NA","title":"Clinical Evaluation Following Use of SYSTANE® ULTRA in the Management of Dry Eye","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2015-06-19","conditions":"Dry Eye Syndrome","enrollment":159},{"nctId":"NCT03183089","phase":"PHASE4","title":"Comparative Study of Rohto Dry-Aid® and Systane® Ultra in Patients With Dry Eye","status":"COMPLETED","sponsor":"The Mentholatum Company","startDate":"2015-12-03","conditions":"Dry Eye Syndromes, Dry Eye","enrollment":80},{"nctId":"NCT01199510","phase":"PHASE4","title":"Efficacy Evaluation of SYSTANE® ULTRA in Patients Scheduled for Cataract Surgery","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2010-09","conditions":"Dry Eye, Cataract Surgery","enrollment":40},{"nctId":"NCT00946777","phase":"NA","title":"Barrier Function Measurement in Dry Eye Patients After Using Systane Ultra for 30 Days","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2009-07","conditions":"Dry Eye","enrollment":19},{"nctId":"NCT01198782","phase":"PHASE4","title":"Evaluating Safety and Efficacy of FID 112903 Post Discontinuation of Long-term Use of RESTASIS® (Cyclosporine Ophthalmic Emulsion) 0.05%","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2010-09","conditions":"Dry Eye Syndrome","enrollment":48},{"nctId":"NCT01863368","phase":"NA","title":"Clinical Evaluation of Systane® ULTRA Compared to OPTIVE® in Ocular Surface Staining","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2013-09","conditions":"Dry Eye Syndrome","enrollment":105},{"nctId":"NCT00938951","phase":"NA","title":"Evaluate the Ability of Systane Ultra to Improve Subjective Symptoms of Ocular Irritation Post 60 Min. Athletic Performance.","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2009-06","conditions":"Dry Eye Symptoms, Visual Performance","enrollment":16},{"nctId":"NCT01417013","phase":"NA","title":"Comparative Efficacy of SYSTANE® ULTRA vs Optive™ in Improving Tear Film Break-up Time","status":"WITHDRAWN","sponsor":"Alcon Research","startDate":"2011-07","conditions":"Dry Eye","enrollment":""},{"nctId":"NCT00769665","phase":"","title":"A 2-week Clinical Comparison of SYSTANE® Ultra to Sensitive Eyes Rewetting Drops in Contact Lens Wearing Patients.","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2008-10","conditions":"Dry Eye","enrollment":47}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Polyethylene glycol 400 0.4%, propyleneglycol 0.3%","Artificial Tears","polyethylene glycol 400, propylene glycol","Administration of Systane Ultra (Alcon)"],"phase":"marketed","status":"active","brandName":"Systane® Ultra","genericName":"Systane® Ultra","companyName":"The Mentholatum Company","companyId":"the-mentholatum-company","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Systane Ultra is a small molecule lubricant eyedrop used to treat Dry Eye Syndrome and related conditions. It is a preservative-free lubricant eyedrop that has been clinically evaluated for its effectiveness in ocular surface staining.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}